Implementation of ERAS guidelines in patients undergoing CRS and HIPEC: need for multicentre trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Implementation of ERAS guidelines in patients undergoing CRS and HIPEC: need for multicentre trial ; volume:9 ; number:1 ; year:2023 ; pages:45-46 ; extent:02
Pleura and peritoneum ; 9, Heft 1 (2023), 45-46 (gesamt 02)
- Creator
-
Iavazzo, Christos
Gkegkes, Ioannis D.
Spiliotis, John
- DOI
-
10.1515/pp-2023-0022
- URN
-
urn:nbn:de:101:1-2024033014361276214507
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Iavazzo, Christos
- Gkegkes, Ioannis D.
- Spiliotis, John
Other Objects (12)
Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC
Etiological analysis of infection after CRS + HIPEC in patients with PMP
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
Reoperationen aufgrund früh-postoperativer Komplikationen nach CRS und HIPEC : Indikation, Ablauf, Prozeduren und Ergebnisse
Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Intraoperative urinary tract resection and construction in CRS + HIPEC procedures: a single center retrospective analysis
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC
Etiological analysis of infection after CRS + HIPEC in patients with PMP
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
Reoperationen aufgrund früh-postoperativer Komplikationen nach CRS und HIPEC : Indikation, Ablauf, Prozeduren und Ergebnisse
Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Intraoperative urinary tract resection and construction in CRS + HIPEC procedures: a single center retrospective analysis
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC
Etiological analysis of infection after CRS + HIPEC in patients with PMP
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
Reoperationen aufgrund früh-postoperativer Komplikationen nach CRS und HIPEC : Indikation, Ablauf, Prozeduren und Ergebnisse
Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Intraoperative urinary tract resection and construction in CRS + HIPEC procedures: a single center retrospective analysis
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis